Episode 166: Vyvyane Loh and Ken Ford discuss atherosclerotic heart disease

Dr. Vyvyane Loh returns to STEM-Talk for her second appearance to talk about atherosclerotic heart disease. Also known as ASCVD, the disease has been reported to affect 26 million people in the U.S., and annually leads two million hospitalizations and more than 400,000 deaths.
Vyvyane is a board-certified physician in obesity and internal medicine. In episode 142 of STEM-Talk, we talked to Vyvyane about her Boston-based preventative-care practice that specializes in weight management and the treatment of chronic metabolic diseases such as diabetes, hypertension and dyslipidemia.
In today’s podcast, Vyvyane and host Dr. Ken Ford talk about ASCVD as well as recent research that has shown substantial individual variability in the response to statin therapy as a way to lower cardiovascular risk. Vyvyane and Ken also discuss how the current knowledge base informing clinical practice in medicine today is far behind advances in the biological sciences, especially in the field of ASCVD.
Read the full show notes at www.ihmc.us/stemtalk/episode-...

[@susanbarr7582]

I love this!
I would live to hear about Lp(a) as well.
Thank you!❤

[@snkdukes7767]

I think most cardiologists and medical researchers know that statins work due to reducing inflammation. The focus on lowering LDL with statins is from the drug companies and their distortion of relative vs absolute risk. Would like to hear discussion about RCT that have looked at aspirin vs statins vs metformin (insert your own antiinflammatory) in heart disease populations.

[@susanbarr7582]

Me to.

[@christinebowman90]

so,eat real food,exercise,manage stress and sleep..basically the same for any metabolic disease.BTW,Ken you should be telling horror stories..your voice is really creepy